Literature DB >> 16423332

Cognitive disturbances in old dogs suffering from the canine counterpart of Alzheimer's disease.

J E Rofina1, A M van Ederen, M J M Toussaint, M Secrève, A van der Spek, I van der Meer, F J C M Van Eerdenburg, E Gruys.   

Abstract

In geriatric dogs, Alzheimer-like behavior is frequently observed. This behavior has been classified by several authors using questionnaires and a correlation has been described between cognitive dysfunctions and Alzheimer-like pathology. In the present study, cognitive performance was correlated with brain pathology for 30 dogs of varying ages. Within these animals, two age-matched groups of old dogs with and without behavioral changes were compared. The behavioral changes were analyzed and scored with questionnaires and necropsy was performed to rule out any other cause for changed behavior. Measurements, (immuno)-histochemical staining and fluorescence microscopy were used to detect cortex atrophy, amyloid, rest-products of oxidative damage, demyelination and accumulations of macrophages in the brains of these dogs. Spearman rank correlation coefficients (r) were calculated and adjusted according to Bonferonni. In the whole group (young to very old dogs), the age of the animal showed a significant correlation with various behavioral changes (r = 0.7 to 0.9, P < 0.01). The dementia score correlated significantly (r = 0.6 to 0.8, P < 0.01) with all the brain lesions studied, except one, i.e. demyelination (r = -0.4, P > 0.05). These results suggest that a questionnaire can be used to diagnose Alzheimer-like changes in canine practice. Oxidative damage on a cellular and a nuclear level plays an important role in behavior changes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16423332     DOI: 10.1016/j.brainres.2005.11.021

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

Review 1.  Antioxidants in the canine model of human aging.

Authors:  Amy L S Dowling; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

2.  Improvement of short-term memory performance in aged beagles by a nutraceutical supplement containing phosphatidylserine, Ginkgo biloba, vitamin E, and pyridoxine.

Authors:  Joseph A Araujo; Gary M Landsberg; Norton W Milgram; Alda Miolo
Journal:  Can Vet J       Date:  2008-04       Impact factor: 1.008

Review 3.  Animal models in the drug discovery pipeline for Alzheimer's disease.

Authors:  Debby Van Dam; Peter Paul De Deyn
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

4.  Adaptive spatial working memory assessments for aging pet dogs.

Authors:  Joshua Van Bourg; Rachel Gilchrist; Clive D L Wynne
Journal:  Anim Cogn       Date:  2020-11-13       Impact factor: 3.084

Review 5.  Demographic history, selection and functional diversity of the canine genome.

Authors:  Elaine A Ostrander; Robert K Wayne; Adam H Freedman; Brian W Davis
Journal:  Nat Rev Genet       Date:  2017-09-25       Impact factor: 53.242

Review 6.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

7.  Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.

Authors:  Lori-Ann Christie; Wycliffe O Opii; Elizabeth Head
Journal:  Age (Dordr)       Date:  2008-06-22

8.  Effects of age, dietary, and behavioral enrichment on brain mitochondria in a canine model of human aging.

Authors:  E Head; V N Nukala; K A Fenoglio; B A Muggenburg; C W Cotman; P G Sullivan
Journal:  Exp Neurol       Date:  2009-08-22       Impact factor: 5.330

Review 9.  Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging.

Authors:  Elizabeth Head
Journal:  Neurochem Res       Date:  2008-08-06       Impact factor: 3.996

10.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.